Literature DB >> 26772481

Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses.

David Méndez-Luna1, Martiniano Bello2, José Correa-Basurto1.   

Abstract

The G-protein coupled receptors (GPCRs) represent the largest superfamily of membrane proteins in charge to pass the cell signaling after binding with their cognate ligands to the cell interior. In breast cancer, a GPCR named GPER1 plays a key role in the process of growth and the proliferation of cancer cells. In a previous study, theoretical methods were applied to construct a model of GPER1, which later was submitted to molecular dynamics (MD) simulations to perform a docking calculation. Based on this preceding work, it is known that GPER1 is sensitive to structural differences in its binding site. However, due to the nature of that past study, conformational changes linked to the ligand binding were not observed. Therefore, in this study, in order to explore the conformational changes coupled to the agonist/antagonist binding, MD simulations of about 0.25μs were performed for the free and bound states, summarizing 0.75μs of MD simulation in total. For the bound states, one agonist (G-1) and antagonist (G-15) were chosen since is widely known that these two molecules cause an impact on GPER1 mobility. Based on the conformational ensemble generated through MD simulations, we found that despite G-1 and G-15 being stabilized by similar map of residues, the structural differences between both ligands impact the hydrogen bond pattern not only at the GPER1 binding site but also along the seven-helix bundle, causing significant differences in the conformational mobility along the extracellular and cytoplasmic domain, and to a lesser degree in the curvatures of helix 2, helix 3 and helix 7 between the free and bound states, which is in agreement with reported literature, and might be linked to microscopic characteristics of the activated-inactivated transition. Furthermore, binding free energy calculations using the MM/GBSA method for the bound states, followed by an alanine scanning analysis allowed us to identify some important residues for the complex stabilization.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Docking; GPER1; Ligand recognition; Molecular dynamics simulations; Principal Component Analysis

Mesh:

Substances:

Year:  2016        PMID: 26772481     DOI: 10.1016/j.jsbmb.2016.01.001

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  6 in total

1.  Phytonutrient genistein is a survival factor for pancreatic β-cells via GPR30-mediated mechanism.

Authors:  Jing Luo; Aihua Wang; Wei Zhen; Yao Wang; Hongwei Si; Zhenquan Jia; Hana Alkhalidy; Zhiyong Cheng; Elizabeth Gilbert; Bin Xu; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-12       Impact factor: 6.048

Review 2.  GPCR Modulation in Breast Cancer.

Authors:  Rosamaria Lappano; Yves Jacquot; Marcello Maggiolini
Journal:  Int J Mol Sci       Date:  2018-12-02       Impact factor: 5.923

3.  Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.

Authors:  Michaël Trichet; Rosamaria Lappano; Mathilde Belnou; Lilian Shadai Salazar Vazquez; Isabel Alves; Delphine Ravault; Sandrine Sagan; Lucie Khemtemourian; Marcello Maggiolini; Yves Jacquot
Journal:  Cells       Date:  2020-02-15       Impact factor: 6.600

4.  Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells.

Authors:  David Méndez-Luna; Loreley Araceli Morelos-Garnica; Juan Benjamín García-Vázquez; Martiniano Bello; Itzia Irene Padilla-Martínez; Manuel Jonathan Fragoso-Vázquez; Alfonso Dueñas González; Nuria De Pedro; José Antonio Gómez-Vidal; Humberto Lubriel Mendoza-Figueroa; José Correa-Basurto
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-10

5.  Optimization of the Urea Removal in a Wearable Dialysis Device Using Nitrogen-Doped and Phosphorus-Doped Graphene.

Authors:  Keyvan Karimi; Mansour Rahsepar
Journal:  ACS Omega       Date:  2022-01-24

Review 6.  Computational Approaches for the Discovery of GPER Targeting Compounds.

Authors:  Fedora Grande; Maria A Occhiuzzi; Rosamaria Lappano; Francesca Cirillo; Rita Guzzi; Antonio Garofalo; Yves Jacquot; Marcello Maggiolini; Bruno Rizzuti
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.